Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Abroad (travel likely)Recruiting

Conditions

Coronary Disease · Heart Diseases · Cardiovascular Diseases · Myocardial Ischemia · Atherosclerosis · Arterial Occlusive Diseases · Vascular Diseases · Coronary Artery Disease · Acute Coronary Syndrome · Coronary Stenosis · Molecular Mechanisms of Pharmacological Action · Enzyme Inhibitors · MTOR Inhibitors · Protein Kinase Inhibitors · Physiological Effects of Drugs · Immunosuppressive Agents · Antineoplastic Agents · High Bleeding Risk · Single Antiplatelet Therapy · Dual Antiplatelet Therapy · Cyclooxygenase Inhibitors · P2Y12 Inhibitor · Platelet Aggregation Inhibitors · Aspirin · Clopidogrel

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

IRCCS Auxologico Milano, Milan, MI, Italy
Contact: Study coordinator (Davide Dr Sala)

View source on ClinicalTrials.gov